Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers

Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers

Source: 
Biopharma Reporter
snippet: 

mRNA technology is a game-changer for Asia-Pacific (APAC) vaccine manufacturers, according to a new report by science and technology company Merck